Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bree B Aldridge

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Cell Chemical Biology|October 2, 2021
Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profilingMichael Li, Hiren V Patel, Armand B Cognetta, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2020
Morphological profiling of tubercle bacilli identifies drug pathways of actionTrever C Smith, Krista M Pullen, Michaela C Olson, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2018
Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of ActionMaikel Boot, Susanna Commandeur, Amit K Subudhi, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Unique growth and morphology properties of Clade 5 <i>Clostridioides difficile</i> strains revealed by single-cell time-lapse microscopyJohn W Ribis, César Nieto, Nicholas V DiBenedetto, et al.
Plos Pathogens|May 21, 2025
Unique growth and morphology properties of Clade 5 Clostridioides difficile strains revealed by single-cell time-lapse microscopyJohn W Ribis, César Nieto, Nicholas V DiBenedetto, et al.
Frontiers in Pharmacology|November 3, 2025
GEODE: an <i>in silico</i> tool that translates <i>in vitro</i> to <i>in vivo</i> predictions of tuberculosis antibiotic combination efficacyMaral Budak, Mariana Pereira Moraes, Talia Greenstein, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Multiomic analysis identifies suppressive myeloid cell populations in human TB granulomasNeharika Jain, Emmanuel C Ogbonna, Zoltan Maliga, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in RabbitsOluwaseun Egbelowo, Jansy P Sarathy, Kamunkhwala Gausi, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
<i>In vitro</i> dormancy models improve ability to predict treatment response in severe marmoset tuberculosis lesionsJoshua J Whiteley, Talia Greenstein, Mariana Pereira Moraes, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2025
Contribution of front-line, standard-of-care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis diseaseNathan Peroutka-Bigus, Elizabeth J Brooks, Michelle E Ramey, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cell Chemical Biology|October 2, 2021
Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profilingMichael Li, Hiren V Patel, Armand B Cognetta, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2020
Morphological profiling of tubercle bacilli identifies drug pathways of actionTrever C Smith, Krista M Pullen, Michaela C Olson, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2018
Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of ActionMaikel Boot, Susanna Commandeur, Amit K Subudhi, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Unique growth and morphology properties of Clade 5 <i>Clostridioides difficile</i> strains revealed by single-cell time-lapse microscopyJohn W Ribis, César Nieto, Nicholas V DiBenedetto, et al.
Plos Pathogens|May 21, 2025
Unique growth and morphology properties of Clade 5 Clostridioides difficile strains revealed by single-cell time-lapse microscopyJohn W Ribis, César Nieto, Nicholas V DiBenedetto, et al.
Frontiers in Pharmacology|November 3, 2025
GEODE: an <i>in silico</i> tool that translates <i>in vitro</i> to <i>in vivo</i> predictions of tuberculosis antibiotic combination efficacyMaral Budak, Mariana Pereira Moraes, Talia Greenstein, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Multiomic analysis identifies suppressive myeloid cell populations in human TB granulomasNeharika Jain, Emmanuel C Ogbonna, Zoltan Maliga, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in RabbitsOluwaseun Egbelowo, Jansy P Sarathy, Kamunkhwala Gausi, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
<i>In vitro</i> dormancy models improve ability to predict treatment response in severe marmoset tuberculosis lesionsJoshua J Whiteley, Talia Greenstein, Mariana Pereira Moraes, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2025
Contribution of front-line, standard-of-care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis diseaseNathan Peroutka-Bigus, Elizabeth J Brooks, Michelle E Ramey, et al.
Pageof 7